Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Musculoskeletal

Bone Diseases Clinical Trials

A listing of Bone Diseases medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

First 1 2 3 4 5 6 Last 

Arizona

Tucson Arizona 85704

A clinical research study of Denosumab and Zoledronic acid

Arkansas

Fayetteville Arkansas 72703

A clinical research study of Denosumab and Zoledronic acid

California

Anaheim California 92801

A clinical research study of Denosumab and Zoledronic acid

Campbell California 95008

A clinical research study of Denosumab and Zoledronic acid

Fresno California 93720

A clinical research study of Denosumab and Zoledronic acid

Pleasant Hill California 94523

A clinical research study of Denosumab and Zoledronic acid

Santa Barbara California 93105

A clinical research study of Denosumab and Zoledronic acid

Colorado

The Urology Center of Colorado
Denver Colorado 80211

Osteonecrosis of the Jaw (ONJ) Case Registry

District of Columbia

Washington District of Columbia 20010

A clinical research study of Denosumab and Zoledronic acid

Florida

Arthritis and Rheumatic Disease Specialities
Aventura Florida 33180

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Center for Arthritis and Rheumatic Diseases
Miami Florida 33173

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Arthritis Center
Palm Harbor Florida 34684

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Sarasota Arthritis Research Center
Sarasota Florida 34239

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Florida Medical Clinic PA
Zephyrhills Florida 33542

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Boynton Beach Florida 33426

A clinical research study of Denosumab and Zoledronic acid

Jacksonville Florida 32256

A clinical research study of Denosumab and Zoledronic acid

Georgia

Savannah Georgia 31405

A clinical research study of Denosumab and Zoledronic acid

Illinois

Deerbrook Medical Associates
Vernon Hills Illinois 60061

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Chicago Illinois 60611

A clinical research study of BMN 111 for the treatment of Achondroplasia

Chicago Illinois 60612

A clinical research study of Denosumab and Zoledronic acid

Joliet Illinois 60435

A clinical research study of Denosumab and Zoledronic acid

Maywood Illinois 60153

A clinical research study of Denosumab and Zoledronic acid

Skokie Illinois 60076

A clinical research study of Denosumab and Zoledronic acid

Skokie Illinois 60077

A clinical research study of Denosumab and Zoledronic acid

Indiana

Dawes-Fretzin Clinical Research
Indianapolis Indiana 46256

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Anderson Indiana 46016

A clinical research study of Denosumab and Zoledronic acid

Fort Wayne Indiana 46845

A clinical research study of Denosumab and Zoledronic acid

Indianapolis Indiana 46202

A clinical research study of Denosumab and Zoledronic acid

Iowa

Ames Iowa 50010

A clinical research study of Denosumab and Zoledronic acid

Iowa City Iowa 52242

A clinical research study of Denosumab and Zoledronic acid

Kentucky

Graves Gilbert Clinic
Bowling Green Kentucky 42101

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Paducah Kentucky 42003

A clinical research study of Denosumab and Zoledronic acid

Maine

Scarborough Maine 04074

A clinical research study of Denosumab and Zoledronic acid

Maryland

Baltimore Maryland 21204

A clinical research study of Denosumab and Zoledronic acid

Baltimore Maryland 21237

A clinical research study of Denosumab and Zoledronic acid

Baltimore Maryland 21229

A clinical research study of Denosumab and Zoledronic acid

Bethesda Maryland 20817

A clinical research study of Denosumab and Zoledronic acid

Westminster Maryland 21157

A clinical research study of Denosumab and Zoledronic acid

Massachusetts

Boston Massachusetts 02215

A clinical research study of Denosumab and Zoledronic acid

Boston Massachusetts 02114

A clinical research study of Denosumab and Zoledronic acid

Danvers Massachusetts 01923

A clinical research study of Denosumab and Zoledronic acid

Fairhaven Massachusetts 02719

A clinical research study of Denosumab and Zoledronic acid

Michigan

Lansing Michigan 48910

A clinical research study of Denosumab and Zoledronic acid

Mississippi

Jackson Mississippi 39216

A clinical research study of Denosumab and Zoledronic acid

Missouri

Clayton Medical Research
St. Louis Missouri 63117

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Springfield Missouri 65807

A clinical research study of Denosumab and Zoledronic acid

Montana

Billings Montana 59101

A clinical research study of Denosumab and Zoledronic acid

Nebraska

Lincoln Nebraska 68506

A clinical research study of Denosumab and Zoledronic acid

Omaha Nebraska 68198

A clinical research study of Denosumab and Zoledronic acid

Nevada

North Las Vegas Nevada 89086

A clinical research study of Denosumab and Zoledronic acid

First 1 2 3 4 5 6 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.